Supreme $FIRE Announces $30MM Bought Deal Private Placement of Convertible Debenture Units

(TSX.V:FIRE) Supreme Pharmaceuticals Inc. announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement … [Read more...]

(TSX.V:NSP) (OTC:NSPDF) (FRANKFURT:50N) Naturally Splendid Enterprises Ltd. is very pleased to announce it has received approval from the Japanese regulatory bodies for two of its CBD capsule products; full spectrum hemp oil NATERA CBD caps and NATERA CBD Ultra Caps. NSE's Natera(R) CBD products … [Read more...]

MX Gold $MXL to Acquire Cryptocurrency Firm

(TSX.V:MXL) (FSE:0DV) (OTCQX:MXLGF) MX Gold Corp. is pleased to announce that the Company has entered into a letter of intent to acquire all of the shares of Symple Internet Financial Ltd., an arm’s length private British Columbia cryptocurrency/blockchain mining company based in Manitoba. The … [Read more...]

Aurora $ACB Announces $6M Complementary Private Placement

(TSX: ACB) (OTCQX: ACBFF) (Frankfurt:  21P; WKN: A1C4WM) Aurora Cannabis Inc. announced that further to the Company's previously announced $60 million bought deal financing, as announced and upsized on October 10, 2017, the Company has agreed to a one-time special accommodation for the benefit of … [Read more...]

Ackroo $AKR to Acquire Software and Hardware Platform From M3 Rebel

(TSX.V: AKR) (OTC PINK: AKRFF) Ackroo Inc. and M3 Rebel are pleased to announce that the two companies have signed a letter of intent for Ackroo to acquire all of the assets relating to KESM/LoyalMark, M3 Rebel's gift card and loyalty processing solution. Under the terms of the acquisition, Ackroo … [Read more...]

HIVE $HIVE Acquires Second Data Centre With $30mm Bought Financial Deal

HIVE Blockchain Technologies Ltd. (TSX.V:HIVE) is pleased to announce that it has closed its previously announced bought deal private placement. A total of 20,000,000 common shares were sold at a price of C$1.50 per Share for aggregate gross proceeds of $30,000,000. The Offering was underwritten by … [Read more...]

InMed $IN Names Mauro Maccarrone to Advisory Board

(CSE: IN; OTCQB: IMLFF) InMed Pharmaceuticals Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Mauro Maccarrone is Professor … [Read more...]